Michelle LeRoux Williams
Chief Tech/Sci/R&D Officer bei ELUTIA INC.
Vermögen: - $ am 31.03.2024
Profil
Michelle LeRoux Williams is currently a member of the American Institute for Medical & Biological Engineering and the Chief Scientific Officer at Elutia, Inc. She was previously the Chief Scientific Officer at Osiris Therapeutics, Inc. from 2009 to 2014.
Dr. Williams holds a doctorate degree from Duke University and an undergraduate degree from Rice University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ELUTIA INC CLASS A
-.--% | 11.04.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Michelle LeRoux Williams
| Unternehmen | Position | Beginn |
|---|---|---|
| ELUTIA INC. | Chief Tech/Sci/R&D Officer | 26.08.2022 |
American Institute For Medical & Biological Engineering
 American Institute For Medical & Biological Engineering Miscellaneous Commercial ServicesCommercial Services American Institute For Medical & Biological Engineering engages in research and development of medical and biological engineering. The private company is based in Washington. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Michelle LeRoux Williams
| Unternehmen | Position | Ende |
|---|---|---|
| OSIRIS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 15.04.2014 |
Ausbildung von Michelle LeRoux Williams
| Duke University | Doctorate Degree |
| Rice University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ELUTIA INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Osiris Therapeutics, Inc.
 Osiris Therapeutics, Inc. BiotechnologyHealth Technology Osiris Therapeutics, Inc. engages in the research, development, manufacture, and commercialization of regenerative medicine products. Its biosurgery business focuses on using unique tissue preservation technologies to develop viable human tissue products designed to improve wound closure and surgical outcomes for patients and physicians over standard of care alone. The company was founded by Peter A. Friedli and James S. Burns on December 23, 1992 and is headquartered in Columbia, MD. | Health Technology |
American Institute For Medical & Biological Engineering
American Institute For Medical & Biological Engineering Miscellaneous Commercial ServicesCommercial Services American Institute For Medical & Biological Engineering engages in research and development of medical and biological engineering. The private company is based in Washington. | Commercial Services |
